NanoViricides Inc. (NNVC)

[JG36]

That sounds like a real low ball estimate. The average cost of a phase III trial is $26,000 per patient. Let's assume that because flu trials are relatively fast that the cost per patient is half that -- $13,000 per patient. Remember that there are many fixed costs that are independent of the length of the trial. With a minimal 1000 patients (most phase III trials have more patients than that) the cost is $13,000,000. I would say that's a realistic estimate, and I wouldn't be surprised if the actual cost turned out to be somewhat higher than that.